Mallemputi Ramakrishna Chowdary
Directeur/Membre du Conseil chez Cronus Pharma Specialities India Pvt Ltd.
Profil
Mallemputi Ramakrishna Chowdary has worked as a Director at Cronus Pharma Specialities India Pvt Ltd.
since 2015 and as a Director at Casper Pharma Pvt Ltd.
since 2016.
Postes actifs de Mallemputi Ramakrishna Chowdary
Sociétés | Poste | Début |
---|---|---|
Cronus Pharma Specialities India Pvt Ltd.
Cronus Pharma Specialities India Pvt Ltd. Pharmaceuticals: MajorHealth Technology Cronus Pharma Specialities India Pvt Ltd. is an Indian pharmaceutical company that manufactures pharmaceutical products. The private company is based in Hyderabad, India and was founded in 2015. | Directeur/Membre du Conseil | 01/09/2015 |
Casper Pharma Pvt Ltd.
Casper Pharma Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Suven Pharmaceuticals Ltd., Casper Pharma Pvt Ltd. is an Indian pharmaceutical company that manufactures pharmaceutical products. The company is based in Hyderabad, India. The company was founded in 2016. Casper Pharma was acquired by Suven Pharmaceuticals Ltd. on June 30, 2022 for $20.75 million. | Directeur/Membre du Conseil | 13/01/2016 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Cronus Pharma Specialities India Pvt Ltd.
Cronus Pharma Specialities India Pvt Ltd. Pharmaceuticals: MajorHealth Technology Cronus Pharma Specialities India Pvt Ltd. is an Indian pharmaceutical company that manufactures pharmaceutical products. The private company is based in Hyderabad, India and was founded in 2015. | Health Technology |
Casper Pharma Pvt Ltd.
Casper Pharma Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Suven Pharmaceuticals Ltd., Casper Pharma Pvt Ltd. is an Indian pharmaceutical company that manufactures pharmaceutical products. The company is based in Hyderabad, India. The company was founded in 2016. Casper Pharma was acquired by Suven Pharmaceuticals Ltd. on June 30, 2022 for $20.75 million. | Health Technology |